Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Arena, Organovo, Isis, & More 06/13/13 San Diego
Rockwell Medical Set to Disrupt Dialysis Treatment With New Drugs, DaVita Deal 05/09/13 Detroit
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly 01/25/12 San Francisco
Acceleron Adds $30M From Partner Celgene and Existing Investors 12/23/11 Boston
Affymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia Drug 12/07/11 San Francisco
Affymax Shares Climb As FDA Considers Wider Use for Anemia Drug 12/05/11 San Francisco
Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny 11/17/11 San Francisco
Acceleron, Celgene Take Aim at Amgen’s Multibillion-Dollar Anemia Market 08/05/11 Boston
Acceleron Gets $25 Million in Partnership Deal With Celgene 08/03/11 Boston
FDA Says It Will Review Affymax Drug 07/27/11 San Francisco
Affymax Raises $50M 03/18/11 San Francisco
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News 01/07/11 San Francisco
Affymax Hires New CEO, Former Genentecher, to Complete FDA Push With Anemia Drug 01/06/11 San Francisco
Alnylam Lays Out 2015 Goals 01/06/11 Boston
Acceleron Pharma Cuts 40 Percent of Workforce 11/03/10 Boston
Taligen Collects $10M For Focus on Rare Diseases 08/23/10 Boston
$8M for Acceleron 06/22/10 Boston
Affymax Tanks on Anemia Results 06/21/10 San Francisco
SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals News 04/07/10 Boston
Avila Gets Leukemia & Lymphoma Society Funding, Dicerna Unites with Ipsen, Rhythmia to Test Heart Mapping Technology, Amag Licenses to Takeda, & More Boston-Area Life Sciences News 04/02/10 Boston
Amag Pharma Gets $60M Upfront in Licensing Deal with Takeda 04/01/10 Boston
Former Idera Pharma CEO at Helm of AesRx, New Startup With Sickle Cell Drug 01/05/10 Boston
Acceleron Pharma Reports $10.9M Financing 12/16/09 Boston
Acceleron Pharma Invests in Bricks & Mortar When Virtual is In Vogue 12/10/09 Boston
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent 10/09/09 National
Acceleron, Bucking Conventional Wisdom, Pushes Ahead Drug For Bone Loss, Anemia 09/11/09 Boston
Acadia Takes a Fall, CareFusion Spins Off, Life Technologies Takes $450M in Cash, & More San Diego Life Sciences News 09/03/09 San Diego
San Diego’s Palkion Chases Amgen’s Big Market, Joins Race to Develop Oral Anemia Drug 09/01/09 San Diego
San Diego Biotech Startups Raise New Cash to Treat Anemia, Heart Disease and More 08/19/09 San Diego
Amag Pharmaceuticals Wins FDA Approval to Sell Iron Deficiency Drug 06/30/09 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.